How to derive and expand primary tumor cell cultures

About the webinar

Established cancer cell lines often fail to reflect the histological and functional features of primary human tumors in contrast to cell cultures derived from primary tumors. However, the derivation of primary tumor cell cultures is challenging.

This webinar covers our latest solutions for improved culture of primary and xenotransplanted tumor cells. We will take a look at our comprehensive cancer research workflow and share insights into:

Dissociation of fresh tumor samples into viable single-cell suspensions.
Untouched isolation of fully viable, heterogeneous tumor cells.
In vitro derivation and expansion of primary and xenotransplanted tumor cell cultures while preserving parental tumor heterogeneity, tumor-initiating capacity, and genetic stability.

Presenter

David J. Agorku

David J. Agorku received his MS in Molecular Life Sciences from the HAN University of Applied Sciences of Nijmegen, the Netherlands, in 2019. In 2015, he joined Miltenyi Biotec in his role as Team Coordinator R&D for Cancer Research and he is currently continuing his studies on the topic as doctoral student.